BFM
PHAS

Boothbay Fund Management’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

Boothbay Fund Management’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-40,727
Closed -$127K – 2156
2021
Q3 		$127K Buy
40,727
+163
+0.4% +$508 ﹤0.01% 1507
2021
Q2 		$151K Buy
40,564
+4,671
+13% +$17.4K ﹤0.01% 1453
2021
Q1 		$124K Buy
35,893
+18,717
+109% +$64.7K ﹤0.01% 1219
2020
Q4 		$58K Buy
+17,176
New +$58K ﹤0.01% 1027